April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Expression Of Cd133 And Abcb5 Protein In Untreated, With Beam Radiation Treated And With Chemotherapy Treated Retinoblastoma Specimens
Author Affiliations & Notes
  • Vinodh Kakkassery
    Department of Ophthalmology, Charite University Hospital, Berlin, Germany
  • Gregor Willerding
    Department of Ophthalmology, Charite University Hospital, Berlin, Germany
  • Sibylle Winterhalter
    Department of Ophthalmology, Charite University Hospital, Berlin, Germany
  • Norbert Kociok
    Department of Ophthalmology, Charite University Hospital, Berlin, Germany
  • Antonia Joussen
    Department of Ophthalmology, Charite University Hospital, Berlin, Germany
  • Footnotes
    Commercial Relationships  Vinodh Kakkassery, None; Gregor Willerding, None; Sibylle Winterhalter, None; Norbert Kociok, None; Antonia Joussen, None
  • Footnotes
    Support  Dr. Werner Jackstädt-Stiftung S 134 – 10.063
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2476. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Vinodh Kakkassery, Gregor Willerding, Sibylle Winterhalter, Norbert Kociok, Antonia Joussen; Expression Of Cd133 And Abcb5 Protein In Untreated, With Beam Radiation Treated And With Chemotherapy Treated Retinoblastoma Specimens. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2476.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Retinoblastoma is the most common, potentially lethal tumor in children. Different treatments like beam radiation and chemotherapy are used to prevent enucleation. Nevertheless, for both therapy options, resistances are commonly seen. It has been postulated that a subpopulation of CD133 positive cells with enhanced tumorigenicity and stem cell like properties trigger this resistance in tumors. ATP-binding cassette (ABC) transporters act as efflux pumps, and ABCB5, a member of the ABC-B subfamily, identifies cancer stem cells in skin melanoma. Objective of this study is to test, whether there is a difference in expression of CD133 and ABCB5 protein in retinoblastoma tumors resistant to radiation or chemotherapy in comparison to untreated tumors.

Methods: : Human specimens of seven subjects with retinoblastoma without therapy, seven subjects with prior beam radiation therapy and seven subjects with prior chemotherapy were fixed in formalin, embedded in paraffin and cut in sections. Diagnosis of these specimens was confirmed by histological evaluation. Expression of CD133 and ABCB5 protein was demonstrated by immunohistological co-staining in all specimens.

Results: : Immunohistochemical analysis showed a higher amount of CD133 and ABCB5 positive cells in prior beam radiation or prior chemotherapy specimens in comparison to untreated specimens. These retinoblastoma cells were cumulated as islets in the tumor.

Conclusions: : First time, we demonstrated CD133- and ABCB5 positive cells in human retinoblastoma tissue and a higher amount of these cells in beam radiation or chemotherapy treated specimens in comparison to untreated specimens. These data support the concept of a stem cell like subpopulation as a therapy resistant mechanism in retinoblastoma tumor.

Keywords: retinoblastoma • microscopy: light/fluorescence/immunohistochemistry • tumors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×